Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) ...

The Charlotte Woodward Organ Transplant Discrimination Act would end the practice of denying transplants to people with Down ...

Alnylam’s drug, vutrisiran, was approved for patients with transthyretin amyloid cardiomyopathy, or ATTR-CM, to reduce ...

Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.

Researchers have shed new light on how a type of heart valve disease -- aortic valve stenosis -- progresses differently in males and females.

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

Mammograms, with the help of artificial intelligence (AI) models, may reveal much more than cancer, according to a study being presented at the American College of Cardiology's Annual Scientific ...

Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...

These flavonoids have antioxidant properties that protect cells from oxidative stress, a process linked to chronic conditions like heart disease and cancer.

Treatment options include medications, dietary changes, lifestyle adjustments, and in severe cases, surgical correction.

A St. Paul family is raising awareness about congenital heart defects among the youngest Minnesotans. A baby is born with a heart defect every 15 minutes, according to the Centers for Disease ...